Two cases of AML-NOS (WHO-HAEM4R) were classified as AML-MR (WHO-HAEM5) and AML-MRC (ICC) because of ASXL1 and SRSF2 mutations and ASXL1 and U2AF1 mutations, respectively. This evidence concerns the gene SRSF2 and intrahepatic cholangiocarcinoma.